Breakthrough Research in Single Ventricle Disease Provides Insights into Pediatric Heart Failure
Breakthrough science often begins with asking difficult clinical questions. Recent research by Dr. James F. Martin, Director of the Cardiomyocyte...
Research & Innovations
Advancing the Science of Heart Regeneration
At The Texas Heart Institute at Baylor College of Medicine, advancing cardiovascular science is central to our mission, and the...
Baylor St. Luke’s First in U.S. with New Precision Surgery Tech
New AI-assisted imaging system enhances precision and efficiency in minimally invasive procedures Baylor St. Luke’s Medical Center, a member of...
Dr. Christie Ballantyne Co-Authors Landmark Publication in the New England Journal of Medicine
The Texas Heart Institute at Baylor College of Medicine congratulates Dr. Christie Ballantyne on co-authoring a newly published study in...
A Legacy of Invention: Dr. Billy Cohn and the Spirit of Innovation at The Texas Heart Institute
Some careers follow established paths. Others create entirely new ones. For decades, William E. Cohn, MD, known to colleagues and...
New Research from Dr. Mehdi Razavi and Team Sheds Light on the Structural Effects of Radiofrequency Ablation on the Heart
A new study led by Dr. Mehdi Razavi, Director of Electrophysiology Clinical Research and Innovations at The Texas Heart Institute...
The Texas Heart Institute at Baylor College of Medicine Researcher Achieves FDA Breakthrough Device Designation for Injectable Defibrillation Technology
A new medical device initiated at The Texas Heart Institute at Baylor College of Medicine, has received FDA Breakthrough Device...
Texas Heart Institute at Baylor College of Medicine Awarded NIH Grant to Explore Immune Cell Role in Heart Failure
The Texas Heart Institute at Baylor College of Medicine’s Gene Editing Lab has been awarded a highly competitive NIH R01...
Electrophysiology Team Pioneers Safer, Smarter Approach to Treating Dangerous Heart Rhythms as Published in Nature
Published in Nature Biomedical Engineering, the breakthrough highlights a novel energy-based technique that could transform the future of arrhythmia care...
Dr. Ajith Nair Contributes to Landmark Study in the New England Journal of Medicine
International trial shows aficamten outperforms standard beta-blocker therapy in patients with obstructive hypertrophic cardiomyopathy. Ajith Nair, MD, Associate Professor...
New England Journal of Medicine Article Highlights Obicetrapib, a New Cholesterol-Lowering Drug for High-Risk Heart Patients
Dr. Christie Ballantyne contributes to global study demonstrating the drug’s potential. A newly published international study, “Safety and Efficacy of...
Breathing New Life Into Lung Transplants: How Researchers at The Texas Heart Institute Are Redefining Organ Preservation
Sadly, every day, lives are lost not because lungs aren’t donated—but because donated lungs don’t arrive in time, or arrive...
